Friday, January 18, 2013

NuPathe wins FDA approval for migraine skin patch

NuPathe Inc., a maker of neurological and psychiatric medicines based in Conshohocken, Pa., won U.S. approval to sell the first skin patch to treat migraines. The treatment, called Zecuity, delivers migraine headache medication through a mild electrical current, according to Bloomberg.net reporter Ryan Flinn. For more background read Senior Reporter John George’s story here. (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Sponsor Message: Have a look at The Psychiatry Daily, the new psychiatry portal powered by MedWorm, with all the latest psychiatry news and research updated daily.





via Original Article

No comments:

Post a Comment